![](/img/cover-not-exists.png)
Pembrolizumab for patients with advanced prostate adenocarcinoma: Preliminary results from the KEYNOTE-028 study
Hansen, A., Massard, C., Ott, P.A., Haas, N., Lopez, J., Ejadi, S., Wallmark, J., Keam, B., Delord, J-P., Aggarwal, R., Gould, M., Qiu, P., Saraf, S., Keefe, S., Piha-Paul, S.A.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw372.09
Date:
October, 2016
File:
PDF, 43 KB
english, 2016